Michael John Rance
Director/Miembro de la Junta en MNLpharma Ltd. .
Cargos activos de Michael John Rance
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
MNLpharma Ltd.
 MNLpharma Ltd. Pharmaceuticals: MajorHealth Technology MNLpharma Ltd. develops and sells pharmaceuticals. It offers therapeutic products, research equipment, and related services. The company developed a molecule Immunomodulators for the treatment of cancer, infectious diseases, and immune disorders. It was founded in 1999 and is headquartered in Aberystwyth, UK | Director/Miembro de la Junta | 21/02/2005 | - |
Historial de carrera de Michael John Rance
Antiguos cargos conocidos de Michael John Rance.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Medical Marketing International Group Plc
 Medical Marketing International Group Plc Medical/Nursing ServicesHealth Services Medical Marketing International Group Plc is a life sciences company that identifies and acquires from academic organisations, technologies that have potential to satisfy unmet needs in major markets, such as cancer and infectious disease. It also offers a range of technical support services to United Kingdom academic and commercial bodies. The Group's operation focuses on the areas of vaccines, chemotherapy and Ribozyme anti-virals. Vaccines relates to diseases such as lymphoma, prostate cancer, CEA cancer, myeloma, CMV, influenza and tubercolosis. Chemotherapy research relates to ruthenium and pineapple protease. The company was founded in 1988 and is headquartered in Cambridge, the United Kingdom. | Director/Miembro de la Junta | - | 19/09/2007 |
AstraZeneca, Inc.
 AstraZeneca, Inc. BiotechnologyHealth Technology Part of AstraZeneca PLC, AstraZeneca, Inc. manufactures vaccines. | Corporate Officer/Principal | - | - |
| Reckitt & Colman Plc | Corporate Officer/Principal | - | - |
| ASTRAZENECA PLC | Public Communications Contact | 25/03/2002 | - |
Estadísticas
Internacional
| Reino Unido | 5 |
| Estados Unidos | 2 |
Operativa
| Corporate Officer/Principal | 2 |
| Director/Board Member | 2 |
| Public Communications Contact | 1 |
Sectorial
| Health Technology | 4 |
| Health Services | 2 |
| Commercial Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| ASTRAZENECA PLC | Health Technology |
| Empresas privadas | 4 |
|---|---|
Medical Marketing International Group Plc
Medical Marketing International Group Plc Medical/Nursing ServicesHealth Services Medical Marketing International Group Plc is a life sciences company that identifies and acquires from academic organisations, technologies that have potential to satisfy unmet needs in major markets, such as cancer and infectious disease. It also offers a range of technical support services to United Kingdom academic and commercial bodies. The Group's operation focuses on the areas of vaccines, chemotherapy and Ribozyme anti-virals. Vaccines relates to diseases such as lymphoma, prostate cancer, CEA cancer, myeloma, CMV, influenza and tubercolosis. Chemotherapy research relates to ruthenium and pineapple protease. The company was founded in 1988 and is headquartered in Cambridge, the United Kingdom. | Health Services |
MNLpharma Ltd.
MNLpharma Ltd. Pharmaceuticals: MajorHealth Technology MNLpharma Ltd. develops and sells pharmaceuticals. It offers therapeutic products, research equipment, and related services. The company developed a molecule Immunomodulators for the treatment of cancer, infectious diseases, and immune disorders. It was founded in 1999 and is headquartered in Aberystwyth, UK | Health Technology |
| Reckitt & Colman Plc | Commercial Services |
AstraZeneca, Inc.
AstraZeneca, Inc. BiotechnologyHealth Technology Part of AstraZeneca PLC, AstraZeneca, Inc. manufactures vaccines. | Health Technology |
- Bolsa de valores
- Insiders
- Michael John Rance
- Experiencia
